Table 2. Differences in primary and secondary outcomes at discharge and 30-day follow-up.
Control group | Intervention group | p-Value | |||
---|---|---|---|---|---|
Primary outcome | ( n = 497) | ( n = 513) | |||
gLOS, days, median [IQR] | 3.23 | [1.75–6.00] | 3.18 | [1.76–5.95] | 0.8 |
Secondary outcome | ( n = 497) | ( n = 513) | |||
LOS, days, median [IQR] | 4.50 | [2.34–7.65] | 4.20 | [2.33–7.51] | 0.8 |
Adverse safety outcomes in scored patients discharged alive. | ( n = 640) | ( n = 661) | |||
30-d re-presentation, no (%) | 115 | (18.0%) | 138 | (20.9%) | 0.2 |
30-d mortality, no (%) | 3 | (0.47%) | 8 | (1.2%) | 0.2 |
Adverse safety outcomes in all scored patients. | ( n = 702) | ( n = 713) | |||
Inpatient mortality/hospice, no (%) | 63 | (9.0%) | 50 | (7.0%) | 0.2 |
Any adverse outcome, no (%) | 178 | (25.3%) | 191 | (26.8%) | 0.6 |
Abbreviations: gLOS, length of stay after first green score; LOS, length of stay; IQR, interquartile range.